SmartScripts

About SmartScripts

SmartScripts operates as a direct-to-consumer online pharmacy, positioning itself as a medication management system. Founded in 2015 by Todd Thompson, R.Ph., and Sam Zoske, the company is headquartered in Washington, Iowa. The inspiration for the business came from Thompson's personal experience watching his aunt struggle to manage multiple daily medications, which highlighted the potential dangers of poor medication adherence. Thompson, who serves as the CEO, has an extensive background in the pharmaceutical industry, with over 20 years of experience that includes roles as CEO of Victor Drug and Reliant Long Term Care, and as a pharmacy manager at Hy Vee.

The company's core service is designed to simplify medication regimens for patients, particularly those with chronic conditions like diabetes or heart disease who manage multiple prescriptions. It achieves this through its main product, the SmartPack, which pre-sorts a patient's daily medications, vitamins, and supplements into individual pouches labeled with the date and time. These 30-day supplies are delivered directly to the customer's home at no extra shipping cost. Revenue is generated from prescription co-pays and the sale of any over-the-counter items added to the packs, with the company accepting most major insurance plans, including Medicare Part D and Medicaid. Beyond pill-based medications, SmartScripts also supplies items like ointments, inhalers, and diabetes testing equipment.

SmartScripts has experienced significant growth, raising a total of $23.8M in funding. In recent years, however, the company has faced considerable legal and regulatory challenges. In August 2025, the Iowa Board of Pharmacy placed SmartScripts on a five-year probation and issued a $25,000 fine for its role in distributing counterfeit Ozempic in late 2023. The company is also involved in multiple lawsuits, including a case where it was ordered to repay over $3 million for misappropriated insurance reimbursements for COVID-19 tests, and another lawsuit from a Michigan pharmacy alleging SmartScripts knowingly sold the counterfeit drugs. The company has also settled class-action lawsuits related to telemarketing practices.